General Information
ISM Supports
15th World Congress on Polyphenols Applications 2022
September 28-30, 2022 - ADEIT, Velencia, Spain
13th International Congress on Skin Ageing & Challenges
November 16-18, 2022 - Lisbon, Portugal
6th World Congress on Targeting Phage & Antibiotic Resistance
June 1-2, 2023
Phage Therapy & Microbiota: Future Directions - Targeting Microbiota 2022
Targeting Microbiota 2022 will introduce you to the most recent advances on using bacteriophages to modulate the gut microbiota in the "Microbiota Innovation, Challenges & Sprints" session.
New Session on Microbiota in Mineral Water & Hot Springs: Unexplored Science

The aim of this session is to discuss the recent advances in microbiota in mineral water as well as in hot springs. It will also highlight the beneficial effects of such bacteria on human health.
Speakers of ISM 2022
FMT 2022: Reorganization and Perspective Peter C. Konturek, President of ISM from the Teaching Hospital of the University of Jena, Germany |
Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France |
Microbiota and Drug Metabolism: Towards a Personalized MedicineCristina Giaroni, University of Insubria, Italy |
|
Christoph Reinhardt, University Mainz, Germany
|
May the Microbiota of the Long-Lived Naked Mole-Rat Affect Human Health?Gerd Birkenmeier, University of Leipzig, Germany |
Understanding the Heterogeneity of Host-associated Microbial CommunitiesLei Dai, Shenzhen Institutes of Advanced Technology, China |
Gut Microbiota-Derived Extracellular Vesicles on Obesity, Diabetes and MetabolismFermin I. Milagro, University of Navarra, Spain |
|
François Leulier, Université de Lyon, France
|
Precision Nutrition to Modulate Gut Microbiota in Reproductive Health and PregnancyAnnalisa Terranegra, Sidra Medical and Research Center, Qatar |
Exploring a Healthy Human Gut Microbiota in a Mediterranean CohortAndrés Moya, University of València, Spain |
Interpreting Microbiomes Via Multi-omics for Precision HealthNathan Price, Thorne HealthTech, USA |
Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated MicrobiotaNicolas Barnich, Université Clermont Auvergne, France
|
Manipulating Fiber Polysaccharide Structure to Alter Targeting to Gut Microbiota Stephen Lindemann, Purdue University, USA |
Short-chain Fatty Acids as Modulators of Redox Signaling in Health and DiseaseCarmen González-Bosch, Universitat de València, Spain |
Proof-of-Principle Demonstration of Endogenous Circadian System and Circadian Misalignment Effects on Human Oral MicrobiotaFrank Scheer, Harvard Medical School, USA |
The Probiotic Strain H. alvei HA4597 for Weight LossPierre Déchelotte, Rouen Normandy University, France |
Probiotics and FMT as Add-On Therapies for DepressionAndré Schmidt, University of Basel, Switzerland |
Oral Microbial Dysbiosis and Oral DiseasesXin Xu, Sichuan University, China |
Microbial Biomarkers to Predict Respiratory InfectionClaire A. Woodall, University of Bristol, United Kingdom |
| Matteo Serino, CRCN INSERM, France |
|
Maria Cecilia Giron, University of Padova, Italy |
| Jarosław Biliński, Medical University of Warsaw, Poland |
|
Benoit Chassaing, Institut Cochin, France
|
|
|
Influence of the Gut Microbiome in Ischemic Stroke Risk and Ischemic Stroke OutcomeMiquel Lledós, Biomedical Research Institute Sant Pau, Spain |
|
Emrah Altindis, Biology Department Boston College, USA
|
Gene Editing and Microbiome TherapyNahla Mansour, National Reseacrh Center, Egypt |
Vaginal Microbiota and Dysbiosis: Recent Advances and PerspectiveGary Ventolini, Texas Tech University Health Sciences Center, USA |
|
Sebastian Granica, Medical University of Warsaw, Poland
|







Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?
















Host-Microbes Mechanisms during E. coli Infections and Diet-induced Dysmetabolism
Cancer Therapy and Microbiota
Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent


A Gut Commensal, Parabacteroides distasonis, and Type 1 Diabetes Onset



























































